Answer
Ropeginterferon alfa-2b is associated with alopecia (hair loss), and stopping treatment must be considered if this appears or worsens.
Sources for this answer
- Besremi 250 micrograms/0.5 mL solution for injection in pre-filled penAOP Orphan Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 10Document updated
Sources checked